Yanyang Tu

2.2k total citations
71 papers, 1.7k citations indexed

About

Yanyang Tu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yanyang Tu has authored 71 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 28 papers in Cancer Research and 16 papers in Oncology. Recurrent topics in Yanyang Tu's work include MicroRNA in disease regulation (14 papers), Glioma Diagnosis and Treatment (12 papers) and Cancer-related molecular mechanisms research (10 papers). Yanyang Tu is often cited by papers focused on MicroRNA in disease regulation (14 papers), Glioma Diagnosis and Treatment (12 papers) and Cancer-related molecular mechanisms research (10 papers). Yanyang Tu collaborates with scholars based in China, United States and Japan. Yanyang Tu's co-authors include Shiming He, Liang Wang, Gang Li, Weilin Jin, Xingchun Gao, Hui Liu, Nan Liu, Yongsheng Zhang, Pengxing Zhang and Zhen Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Yanyang Tu

66 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanyang Tu China 26 1.2k 749 288 248 154 71 1.7k
Kiran Kumar Velpula United States 27 1.1k 0.9× 660 0.9× 431 1.5× 324 1.3× 327 2.1× 62 2.0k
Maode Wang China 22 1.2k 1.0× 768 1.0× 479 1.7× 461 1.9× 175 1.1× 71 1.9k
Yanhua Zheng China 13 1.2k 1.0× 633 0.8× 231 0.8× 87 0.4× 187 1.2× 29 1.7k
Shizuka Seino Japan 26 1.4k 1.1× 457 0.6× 614 2.1× 303 1.2× 127 0.8× 44 2.0k
Maria Chiara De Santis Italy 14 1.0k 0.8× 333 0.4× 287 1.0× 107 0.4× 124 0.8× 18 1.6k
Candace A. Gilbert United States 13 765 0.6× 320 0.4× 480 1.7× 155 0.6× 107 0.7× 17 1.3k
Mingzhi Han China 21 795 0.6× 429 0.6× 215 0.7× 147 0.6× 154 1.0× 39 1.2k

Countries citing papers authored by Yanyang Tu

Since Specialization
Citations

This map shows the geographic impact of Yanyang Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanyang Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanyang Tu more than expected).

Fields of papers citing papers by Yanyang Tu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanyang Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanyang Tu. The network helps show where Yanyang Tu may publish in the future.

Co-authorship network of co-authors of Yanyang Tu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanyang Tu. A scholar is included among the top collaborators of Yanyang Tu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanyang Tu. Yanyang Tu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tu, Yanyang, et al.. (2025). Autophagy in doxorubicin resistance: basic concepts, therapeutic perspectives and clinical translation. Frontiers in Immunology. 16. 1642050–1642050.
2.
Liu, Chenxiao, et al.. (2025). Adoptive immune cell therapy for colorectal cancer. Frontiers in Immunology. 16. 1557906–1557906. 2 indexed citations
3.
Zhang, Meng, Lixia Liu, B. Liu, et al.. (2024). Exploring non-coding RNA mechanisms in hepatocellular carcinoma: implications for therapy and prognosis. Frontiers in Immunology. 15. 1400744–1400744. 14 indexed citations
4.
Ling, Yunzhi, et al.. (2023). FBLIM1 mRNA is a novel prognostic biomarker and is associated with immune infiltrates in glioma. Open Medicine. 18(1). 20230863–20230863.
5.
Li, Yongshu, Yuanyuan Yu, Zhenjian Zhuo, et al.. (2023). The application of Aptamer in biomarker discovery. Biomarker Research. 11(1). 70–70. 46 indexed citations
6.
Gao, Wenzhe, Jie Shen, Feng Guo, et al.. (2019). Roles of pyroptosis in myocardial ischemia/reperfusion injury diseases. 1(3). 184–189. 1 indexed citations
7.
Xu, Xiaoshan, Zhen Wang, Nan Liu, et al.. (2018). Association between SOX9 and CA9 in glioma, and its effects on chemosensitivity to TMZ. International Journal of Oncology. 53(1). 189–202. 31 indexed citations
8.
Tu, Yanyang, Hui Liu, Hongwei Yang, & Xin Wang. (2018). The contribution of hexokinase 2 in glioma. SHILAP Revista de lepidopterología. 4(2). 54–54. 5 indexed citations
9.
Zhang, Pengxing, Xin Wang, Weihong Wen, et al.. (2017). A novel indication of thioredoxin-interacting protein as a tumor suppressor gene in malignant glioma. Oncology Letters. 14(2). 2053–2058. 22 indexed citations
10.
Tu, Yanyang, Zhen Wang, Hong Yang, et al.. (2016). The molecular mechanism and regulatory pathways of cancer stem cells. SHILAP Revista de lepidopterología. 2(5). 147–147. 5 indexed citations
11.
Tu, Yanyang, Zhen Wang, Xin Wang, et al.. (2016). Birth of MTH1 as a therapeutic target for glioblastoma: MTH1 is indispensable for gliomatumorigenesis.. PubMed. 8(6). 2803–11. 30 indexed citations
12.
Liu, Hui, Gang Li, Pengxing Zhang, et al.. (2014). Combined detection of Gab1 and Gab2 expression predicts clinical outcome of patients with glioma. Medical Oncology. 31(8). 77–77. 12 indexed citations
13.
Wei, Haibin, Ben Zhou, Fang Zhang, et al.. (2013). Profiling and Identification of Small rDNA-Derived RNAs and Their Potential Biological Functions. PLoS ONE. 8(2). e56842–e56842. 67 indexed citations
14.
Wang, Liang, Shiming He, Yanyang Tu, et al.. (2013). Downregulation of chromatin remodeling factor CHD5 is associated with a poor prognosis in human glioma. Journal of Clinical Neuroscience. 20(7). 958–963. 26 indexed citations
15.
Li, Gang, Zhiguo Zhang, Yanyang Tu, et al.. (2013). Correlation of microrna-372 upregulation with poor prognosis in human glioma. Diagnostic Pathology. 8(1). 1–1. 60 indexed citations
16.
Zhang, Guozhong, Yanyang Tu, Wenfeng Feng, et al.. (2011). Association of interleukin-6-572G/C gene polymorphisms in the Cantonese population with intracranial aneurysms. Journal of the Neurological Sciences. 306(1-2). 94–97. 21 indexed citations
17.
He, Shiming, Lianshu Ding, Gang Li, et al.. (2011). Overexpression of a disintegrin and metalloprotease 8 in human gliomas is implicated in tumor progression and prognosis. Medical Oncology. 29(3). 2032–2037. 12 indexed citations
18.
Fu, Jianfang, Yang Liu, Ruiyu Li, et al.. (2011). Modulatory effects of one polysaccharide from Acanthopanax senticosus in alloxan-induced diabetic mice. Carbohydrate Polymers. 87(3). 2327–2331. 25 indexed citations
19.
Wang, Xinming, Xiang Gao, Yanyang Tu, et al.. (2006). The negative cell cycle regulator, Tob (transducer of ErbB-2), is involved in motor skill learning. Biochemical and Biophysical Research Communications. 340(4). 1023–1027. 25 indexed citations
20.
Tu, Yanyang, et al.. (2003). Reinforcement of nimodipine to the TK suicide gene therapy of glioma. 10(11). 1129–1133. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kiran Kumar Velpula Breakdown of academic impact, for papers by Maode Wang Breakdown of academic impact, for papers by Yanhua Zheng Breakdown of academic impact, for papers by Shizuka Seino Breakdown of academic impact, for papers by Maria Chiara De Santis Breakdown of academic impact, for papers by Candace A. Gilbert Breakdown of academic impact, for papers by Mingzhi Han
Rankless by CCL
2026